Literature DB >> 24055468

Antidiabetic effects of Swertia macrosperma extracts in diabetic rats.

Yong-Long Wang1, Zuo-Qi Xiao, Shan Liu, Luo-Sheng Wan, Yao-Dong Yue, Yu-Tang Zhang, Zhao-Xia Liu, Jia-Chun Chen.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Swertia macrosperma is a traditional folk medicine used for its anti-hepatitis, antipyretic and antidotal effects as "Dida" or "Zangyinchen" in Tibet, Yunnan and Guizhou province for a long time, and it has been reported for its anti-diabetic effects in a Chinese patent. Swertia macrosperma was reported rich in xanthones, iridoids, seco-iridoids and their glycosides, several of which had been documented as potential antidiabetic agents. The objective of this study was to investigate the antidiabetic effect of Swertia macrosperma in diabetic rats.
MATERIALS AND METHODS: This study was designed firstly to evaluate the effect of Swertia macrosperma on glucose consumption in HepG2 cells. Based on the result in HepG2 cells, the antidiabetic effect of ethanol extract (EE) and n-butanol extract (BE) were investigated in diabetic rats induced by high fat fed and streptozotocin. The effects of EE and BE on fasting blood glucose, oral glucose tolerance test, serum insulin, glycosylated hemoglobin, serum lipid level, serum antioxidant parameters, glucokinase, glucose-6-phosphatase activities and glycogen content in liver tissue were measured, histology examination of pancreatic tissue was also carried out.
RESULTS: After 4 weeks treatment with EE and BE, apparently decreased fasting blood glucose concentrations were observed in these treated groups, compared with the diabetic control groups. Additionally, improvement in serum antioxidant parameters and lipid profile were evidenced clearly. Moreover, EE and BE had effects of protecting the pancreatic β-cells and stimulating insulin secretion from the remaining pancreatic β-cells, evidenced by pancreatic histology examination. Increased glucokinase activity and decreased glucose-6-phosphatase activity were observed in liver.
CONCLUSION: The results of in vivo and in vitro experiment suggested that EE and BE of Swertia macrosperma had excellent effects on controlling the hyperglycemia and hyperlipidemia in diabetic rats.
© 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anti-diabetes; Diabetic rat; Extracts; HepG2 cell; Swertia macrosperma

Mesh:

Substances:

Year:  2013        PMID: 24055468     DOI: 10.1016/j.jep.2013.08.053

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

Review 1.  Antidiabetic Potential of Medicinal Plants and Their Active Components.

Authors:  Bahare Salehi; Athar Ata; Nanjangud V Anil Kumar; Farukh Sharopov; Karina Ramírez-Alarcón; Ana Ruiz-Ortega; Seyed Abdulmajid Ayatollahi; Patrick Valere Tsouh Fokou; Farzad Kobarfard; Zainul Amiruddin Zakaria; Marcello Iriti; Yasaman Taheri; Miquel Martorell; Antoni Sureda; William N Setzer; Alessandra Durazzo; Massimo Lucarini; Antonello Santini; Raffaele Capasso; Elise Adrian Ostrander; Muhammad Iqbal Choudhary; William C Cho; Javad Sharifi-Rad
Journal:  Biomolecules       Date:  2019-09-30

2.  Identification of mangiferin as a potential Glucokinase activator by structure-based virtual ligand screening.

Authors:  Qiuxia Min; Xinpei Cai; Weiguang Sun; Fei Gao; Zhimei Li; Qian Zhang; Luo-Sheng Wan; Hua Li; Jiachun Chen
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

Review 3.  Herbal Medicines Targeting the Improved β-Cell Functions and β-Cell Regeneration for the Management of Diabetes Mellitus.

Authors:  Akurange Sujeevi Dammadinna Wickramasinghe; Pabasara Kalansuriya; Anoja Priyadarshani Attanayake
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-14       Impact factor: 2.629

4.  Hypoglycemic Activity and the Potential Mechanism of the Flavonoid Rich Extract from Sophora tonkinensis Gagnep. in KK-Ay Mice.

Authors:  Mi Huang; Shihao Deng; Qianqian Han; Ping Zhao; Qi Zhou; Sijian Zheng; Xinhua Ma; Chan Xu; Jing Yang; Xinzhou Yang
Journal:  Front Pharmacol       Date:  2016-09-05       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.